Literature DB >> 15809201

Cultured alveolar macrophages from patients with idiopathic pulmonary fibrosis (IPF) show dysregulation of lipopolysaccharide-induced tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) inductions.

Robin W Freeburn1, Lynne Armstrong, Ann B Millar.   

Abstract

Regulation of the pulmonary host defence mechanism is crucial for protection of the lung without pathological consequences. This is exemplified in the normal lung by the induction of both the pro-inflammatory cytokine TNF-alpha, its receptors and the anti-inflammatory cytokine IL-10 by bacterial lipopolysaccharide (LPS). We have evaluated this mechanism in patients with idiopathic pulmonary fibrosis (IPF). Alveolar macrophages (AM) were obtained by bronchoalveolar lavage from 21 subjects with IPF and 12 healthy volunteers. Constitutive and LPS-stimulated AM production of TNF-alpha, TNF soluble receptors CD120a and CD120b, and IL-10 at the protein and mRNA level were measured by bioassay, ELISA and competitive PCR respectively. AM from IPF subjects were more susceptible to LPS induction of TNF-alpha protein (P = 0.03) and transcription of IL-10 mRNA (P = 0.01) and IL-10R1 (P = 0.01) expression in comparison to controls. In contrast, increased CD120b was present as protein and mRNA compared to controls (P = 0.02). AM from IPF subjects were at least as susceptible to down-regulation of LPS-induced TNF-alpha levels by exogenous IL-10 as normal controls (94% versus 63%). These data suggest that there is dysregulation of LPS-induced TNF-alpha and IL-10 in AM from IPF subjects. Further studies are required to elucidate these observations, which may, in turn, give additional insight into the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809201

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  9 in total

1.  Expression of the immunomodulator IL-10 in type I pneumocytes of the rat: alterations of IL-10 expression in radiation-induced lung damage.

Authors:  Michael G Haase; Anke Klawitter; Peter Geyer; Gustavo B Baretton
Journal:  J Histochem Cytochem       Date:  2007-08-06       Impact factor: 2.479

2.  IL-10: Another therapeutic target in idiopathic pulmonary fibrosis?

Authors:  A B Millar
Journal:  Thorax       Date:  2006-10       Impact factor: 9.139

3.  In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung.

Authors:  K Nakagome; M Dohi; K Okunishi; R Tanaka; J Miyazaki; K Yamamoto
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

4.  Tumour necrosis factor-alpha processing in interstitial lung disease: a potential role for exogenous proteinase-3.

Authors:  L Armstrong; S I H Godinho; K M Uppington; H A Whittington; A B Millar
Journal:  Clin Exp Immunol       Date:  2009-03-09       Impact factor: 4.330

Review 5.  Determinants of initiation and progression of idiopathic pulmonary fibrosis.

Authors:  Robert Matthew Kottmann; Christopher M Hogan; Richard P Phipps; Patricia J Sime
Journal:  Respirology       Date:  2009-09       Impact factor: 6.424

6.  LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanisms.

Authors:  Hugues Chanteux; Amélie C Guisset; Charles Pilette; Yves Sibille
Journal:  Respir Res       Date:  2007-10-04

Review 7.  Macrophage heterogeneity in respiratory diseases.

Authors:  Carian E Boorsma; Christina Draijer; Barbro N Melgert
Journal:  Mediators Inflamm       Date:  2013-02-27       Impact factor: 4.711

Review 8.  Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis.

Authors:  Thị Hằng Giang Phan; Panagiotis Paliogiannis; Gheyath K Nasrallah; Roberta Giordo; Ali Hussein Eid; Alessandro Giuseppe Fois; Angelo Zinellu; Arduino Aleksander Mangoni; Gianfranco Pintus
Journal:  Cell Mol Life Sci       Date:  2020-11-17       Impact factor: 9.261

Review 9.  The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis.

Authors:  Emily H Steen; Xinyi Wang; Swathi Balaji; Manish J Butte; Paul L Bollyky; Sundeep G Keswani
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-02-07       Impact factor: 4.947

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.